Cambridge Investment Research Advisors’s Target TGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1M Sell
131,136
-8,251
-6% -$1.05M 0.04% 460
2026
Q1
$16.9M Buy
139,387
+4,280
+3% +$483K 0.04% 425
2025
Q4
$13.2M Buy
135,107
+19,565
+17% +$1.8M 0.03% 492
2025
Q3
$10.4M Buy
115,542
+660
+0.6% +$65K 0.03% 552
2025
Q2
$11.3M Buy
114,882
+16,328
+17% +$1.57M 0.03% 497
2025
Q1
$10.3M Buy
98,554
+4,553
+5% +$569K 0.03% 497
2024
Q4
$12.7M Buy
94,001
+7,052
+8% +$1.01M 0.04% 413
2024
Q3
$13.6M Buy
86,949
+3,119
+4% +$465K 0.05% 397
2024
Q2
$12.4M Sell
83,830
-4,399
-5% -$692K 0.05% 399
2024
Q1
$15.6M Sell
88,229
-27
-0% -$4.11K 0.06% 316
2023
Q4
$12.6M Buy
88,256
+226
+0.3% +$27.6K 0.05% 325
2023
Q3
$9.73M Sell
88,030
-6,361
-7% -$808K 0.05% 388
2023
Q2
$12.4M Sell
94,391
-21,459
-19% -$3.18M 0.06% 324
2023
Q1
$19.2M Buy
115,850
+2,132
+2% +$351K 0.09% 227
2022
Q4
$16.9M Sell
113,718
-18,883
-14% -$2.96M 0.09% 222
2022
Q3
$19.7M Sell
132,601
-27,953
-17% -$4.48M 0.11% 190
2022
Q2
$22.7M Buy
160,554
+22,207
+16% +$4.26M 0.12% 169
2022
Q1
$29.4M Buy
138,347
+9,058
+7% +$1.96M 0.13% 161
2021
Q4
$29.9M Buy
129,289
+6,414
+5% +$1.56M 0.13% 159
2021
Q3
$28.1M Buy
122,875
+504
+0.4% +$126K 0.14% 153
2021
Q2
$29.6M Buy
122,371
+5,762
+5% +$1.26M 0.14% 143
2021
Q1
$23.1M Buy
116,609
+19,368
+20% +$3.63M 0.13% 169
2020
Q4
$17.2M Buy
97,241
+4,124
+4% +$688K 0.1% 200
2020
Q3
$14.7M Buy
93,117
+803
+0.9% +$110K 0.1% 208
2020
Q2
$11.1M Buy
92,314
+6,302
+7% +$719K 0.08% 241
2020
Q1
$8M Sell
86,012
-18,792
-18% -$2.09M 0.08% 248
2019
Q4
$13.4M Buy
104,804
+9,496
+10% +$1.11M 0.1% 201
2019
Q3
$10.2M Buy
95,308
+5,865
+7% +$558K 0.09% 230
2019
Q2
$7.75M Buy
89,443
+6,270
+8% +$507K 0.07% 267
2019
Q1
$6.67M Buy
83,173
+10,314
+14% +$754K 0.06% 279
2018
Q4
$4.82M Sell
72,859
-4,805
-6% -$370K 0.05% 337
2018
Q3
$6.85M Buy
77,664
+4,316
+6% +$359K 0.07% 285
2018
Q2
$5.58M Sell
73,348
-928
-1% -$68.3K 0.06% 300
2018
Q1
$5.16M Sell
74,276
-7,662
-9% -$558K 0.06% 314
2017
Q4
$5.35M Buy
81,938
+2,765
+3% +$167K 0.06% 294
2017
Q3
$4.67M Sell
79,173
-2,069
-3% -$116K 0.06% 292
2017
Q2
$4.25M Buy
+81,242
New +$4.44M 0.06% 290
2016
Q4
Sell
-78,878
Closed -$5.42M 1807
2016
Q3
$5.42M Buy
+78,878
New +$5.65M 0.1% 185
2016
Q2
Sell
-60,003
Closed -$4.94M 1674
2016
Q1
$4.94M Sell
60,003
-2,611
-4% -$197K 0.11% 169
2015
Q4
$4.55M Buy
+62,614
New +$4.67M 0.11% 177
2015
Q3
Sell
-42,935
Closed -$3.5M 1578
2015
Q2
$3.5M Buy
42,935
+253
+0.6% +$20.5K 0.1% 206
2015
Q1
$3.5M Sell
42,682
-1,502
-3% -$116K 0.1% 205
2014
Q4
$3.35M Sell
44,184
-621
-1% -$41.9K 0.1% 186
2014
Q3
$2.81M Buy
44,805
+1,982
+5% +$120K 0.08% 237
2014
Q2
$2.48M Buy
42,823
+9,499
+29% +$559K 0.09% 227
2014
Q1
$2.02M Sell
33,324
-2,100
-6% -$124K 0.08% 257
2013
Q4
$2.24M Sell
35,424
-1,269
-3% -$81.1K 0.09% 204
2013
Q3
$2.35M Sell
36,693
-489
-1% -$33.3K 0.1% 192
2013
Q2
$2.56M Buy
+37,182
New +$2.59M 0.13% 153

Other funds holding TGT

Cambridge Investment Research Advisors's TGT Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Target (TGT) stake by 5.9% in Q2 2026, selling an estimated $1.05M and leaving 131,136 shares worth $17.1M. The position accounts for 0.04% of the portfolio, ranked #460.

Cambridge Investment Research Advisors first reported a position in TGT in Q2 2013 and has held it in 49 quarters since. The position peaked at $29.9M in Q4 2021. 862 funds tracked by Wall St. Rank hold TGT as of Q2 2026.

  • Cambridge Investment Research Advisors held 131,136 shares of Target worth $17.1M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 8,251 Target shares in Q2 2026, an estimated $1.05M.
  • Target made up 0.04% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #460 holding.
  • Cambridge Investment Research Advisors first reported a position in Target in Q2 2013 and has held it in 49 quarters since.
  • Cambridge Investment Research Advisors's Target position peaked at $29.9M in Q4 2021.
  • 862 funds tracked by Wall St. Rank held Target as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.